Aardvark Therapeutics
Develops gut-restricted oral programs for hunger-associated conditions and obesity.
$6.14
After-hours close+0.36 (+6.23%)
At close$5.78(−12.69%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 46.61%10.20M sharesInsiders 14.14%3.09M sharesOther 39.25%8.59M shares
Shares outstanding 21.88M · Float 10.91M · 49.9% free float
A Form 4 total here can count shares the filer formally disclaims — an award voted by proxy, for instance — which the holder's own Schedule 13D/G excludes, so where the two disagree the schedule's smaller figure is used.
Institutions13F, as of Mar 31, 2026
81 holders · 10.20M shares · 34 new positions · 50 increased · 23 reduced · 19 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Decheng Capital LLC | 3.92M | 17.90% | 0 | May 13, 2026 |
| Citadel Advisors LLC | 1.24M | 5.68% | −46.5K | May 15, 2026 |
| Laurion Capital Management LP | 1.03M | 4.73% | +19.5K | May 14, 2026 |
| BlackRock, Inc. | 792.6K | 3.62% | +8.1K | May 13, 2026 |
| Vanguard Capital Management LLC | 554.1K | 2.53% | +554.1Knew | May 15, 2026 |
| TFG Asset Management GP Ltd | 316.6K | 1.45% | +316.6Knew | May 15, 2026 |
| Geode Capital Management, LLC | 309.4K | 1.41% | +11.6K | May 15, 2026 |
| Adage Capital Partners GP, L.L.C. | 300.0K | 1.37% | +300.0K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P. | 13.80% | 2.96M | 13G | Feb 24, 2025 ↗ |
| Tien-Li Lee | 13.70% | 2.98M | 13G | May 15, 2025 ↗ |
| Dr. Finian Tan | 8.69% | 1.83M | 13G | Feb 24, 2025 ↗ |
| Citadel Advisors LLC | 5.40% | 1.15M | 13G | Feb 24, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Tien-Li Lee | director, 10 percent owner, officer: Chief Executive Officer | 2.98M | 13.63% | Dec 12, 2025 |
| Nelson Sun | officer: Chief Financial Officer | 108.5K | 0.50% | Dec 12, 2025 |
| Bryan Jones | officer: Chief Operating Officer | 1.3K | 0.01% | Oct 16, 2025 |
3 ten-percent owners hold 2.77M shares by Form 4, outside the officers-and-directors figure above · 2 people have not refiled in the last 18 months (133.7K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Dec 11, 2025 | Tien-Li Leedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 7,000 | $14.49 | 1,551,613 |
| Dec 11, 2025 | Nelson Sunofficer: Chief Financial Officer | Purchase | 3,000 | $14.40 | 108,484 |
| Sep 15, 2025 | Tien-Li Leedirector, 10 percent owner, officer: Chief Executive Officer | Purchase · 2 lots | 10,000 | $9.66 | 1,543,384 |
| Sep 10, 2025 | Tien-Li Leedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 9,000 | $7.91 | 1,522,384 |
| Sep 11, 2025 | Tien-Li Leedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 6,000 | $7.82 | 1,528,384 |
| Sep 12, 2025 | Tien-Li Leedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 5,000 | $8.50 | 1,533,384 |
| Sep 9, 2025 | Nelson Sunofficer: Chief Financial Officer | Purchase | 6,000 | $8.07 | 105,484 |
CongressHouse and Senate disclosures
Not reported.